Investor Relations

Twelve Months Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at ENDO 2015 Conference more »

OPKO Announces Fourth Quarter Operating and Financial Results more »

OPKO to Announce Fourth Quarter and Full Year 2014 Financial Results on February 27, 2015 more »

OPKO Announces Publication of 20 Year Outcome Study for Lethal Prostate Cancer Using Kallikrein Biomarkers in 4Kscore Test more »

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.

  • Events

  • Stock Information

Ticker OPK Exchange NYSE
Last Price 14.37 Change 0.03 down
Open 14.24 Previous Close 14.40
Day High 14.52 Day Low 14.13
52-Week High 15.23 52-Week Low 7.82
Quotes delayed at least 20 minutes. Information provided by eSignal.